That stock is Chrysos Corporation Ltd (ASX: C79), which provides novel assay services to the global mining industry through its proprietary PhotonAssay technology.

PhotonAssay can be used to detect a wide range of elements, but the technology has been particularly effective for assaying gold and is currently being rolled‑out across the gold mining industry.

Bell Potter is a big fan of the company and is recommending the stock to clients following its half-year results release this month.

What is the broker saying?

The broker notes that the ASX mining technology stock delivered a half-year result that was ahead of expectations thanks to higher PhotonAssay fleet utilisation. It said:

Total revenue was $43.3m (BPe $41.7m), up 49% YoY, with MMAP of $31.5m (BPe $32.6m), up 22% YoY, and AAC of $11.7m (BPe $9.1m), up 261% YoY. MMAP growth was driven by an expansion in the installed base. The significant uptick in AAC was due to higher PhotonAssay fleet utilisation as rising global exploration activity drove greater samples processed. Four additional units were deployed during the half, taking total units installed and operational to 43. GM was 76.3% (BPe 78.0%), up from 72.9% in the PcP.

EBITDA of $14.4m (BPe $13.2m) was up 152%, with margins improving to 33.1% (BPe 31.6%), up from 19.5% in the PcP, reflecting operating leverage and greater AAC. Underlying NPAT was $0.7m (BPe $1.8m), up from a $2.6m loss in the PcP.

Guidance upgrade

Bell Potter was also pleased to see that management has upgraded its guidance for the full year. It adds:

A soft upgrade was delivered: Revenue is now tracking towards the top-end of the $80-90m range (BPe $90.8m old); and EBITDA is now tracking towards the top-end of the $20-27m range (BPe $29.6m old). We see guidance as conservative due to: 1) an acceleration in deployment cadence in 2H FY26 given the significant expansion in the backlog following the 14 new lease agreements secured in FY26TD; and 2) strong ongoing momentum in exploration activity enhancing the outlook for AAC generation.

Strong potential returns

According to the note, the broker has retained its buy rating and $9.40 price target on the ASX mining technology stock.

Based on its current share price of $7.93, this implies potential upside of 19% for investors over the next 12 months.

Commenting on its buy recommendation, the broker concludes:

We are encouraged by the 14 lease agreements signed in FY26TD, expanding on existing relationships and securing contracts with new prospective clients. Together, with the landmark Newmont MSA, the increased contract award momentum signals an acceleration in PhotonAssay adoption, which is a key tenet to our Buy thesis.

The post Here's an exciting ASX mining technology stock to buy appeared first on The Motley Fool Australia.

But never fear! Summarised below are three recent recommendations that remain very relevant today. Here's what brokers are saying about these ASX shares:

Chrysos Corporation Ltd (ASX: C79)

According to a note out of Bell Potter, its analysts upgraded this mining technology company's shares to a buy rating with an improved price target of $9.40. This followed the release of a trading update from Chrysos' annual general meeting. Bell Potter noted that Chrysos started FY 2026 strongly and reported a 54% increase in revenue year to date. This was ahead of the broker's estimates. Looking ahead, Bell Potter believes that this trend can continue. It points out that Chrysos' industry adoption has accelerated over the past 12 months with the signing of the master services agreement with Newmont Corporation (ASX: NEM) and the broadening of relationships with commercial lab operators. In addition, Bell Potter believes the exploration upcycle should deliver further upside, which could lead to Chrysos comfortably outperforming its EBITDA guidance this year. The Chrysos share price is trading at $7.31 this afternoon.

Megaport Ltd (ASX: MP1)

A note out of Macquarie revealed that its analysts retained their outperform rating on this network solutions company's shares with an increased price target of $21.70. Macquarie noted that the recent acquisition of India-based Latitude expands its immediate addressable share of customer wallet. The broker points out that customers already consume compute products, but Megaport has not historically sold compute. As a result, Latitude's product offering is highly complementary to the existing product set and offers a direct position in a large and fast-growing end market. It estimates that Bare Metal as a Service (BMaaS) is a large, end market currently worth US$15 billion, and growing rapidly. Combined with the stabilisation of its core revenue, Macquarie believes this leaves Megaport well-placed for long term growth. The Megaport share price is fetching $12.21 at the time of writing.

Zip Co Ltd (ASX: ZIP)

Another note out of Macquarie revealed that its analysts retained their outperform rating and $4.85 price target on this buy now pay later provider's shares. The broker thinks that Zip will deliver on its net transaction margin guidance in FY 2026 despite elevated loss rates that are being caused by its accelerating total transaction value (TTV) growth. Outside this, Macquarie is forecasting Zip to continue to deliver rapid growth supported by increased product adoption, expansion of its merchant network, increased customer engagement, and digital product innovation. The Zip share price is trading at $3.22 on Wednesday afternoon.

The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

Three ASX shares that brokers have named as buys this week are listed below. Here's why their analysts are feeling bullish on them right now:

Chrysos Corporation Ltd (ASX: C79)

According to a note out of Bell Potter, its analysts have upgraded this mining technology company's shares to a buy rating with an improved price target of $9.40. This follows the release of a trading update at its annual general meeting. Bell Potter notes that Chrysos has started FY 2026 strongly, with revenue up 54% year to date. This is ahead of the broker's estimates. The good news is that it appears to believe that this trend can continue. It highlights that Chrysos' industry adoption has accelerated over the past 12 months with the signing of the master services agreement with Newmont and the broadening of relationships with commercial lab operators. In addition, the exploration upcycle should deliver further upside. So much so, it estimates that the company will comfortably outperform its EBITDA guidance this year. The Chrysos share price is trading at $8.04 this afternoon.

Lovisa Holdings Ltd (ASX: LOV)

A note out of Morgans reveals that its analysts have upgraded this fashion jewellery retailer's shares to a buy rating with a trimmed price target of $40.00. This follows the release of a trading update from Lovisa covering the first 20 weeks of FY 2026. Morgans notes that the company's sales and store growth have slowed over the past three months. However, it is still growing sales at 20%+, which is impressive given the challenging retail trading conditions. In light of this and the recent pullback in its share price, Morgans thinks that it is a great opportunity to buy a high quality retailer with a global store rollout opportunity. Especially given that its shares are trading back around their average 10-year forward earnings multiple and offering ~20% EPS compound annual growth over the next 3 years. The Lovisa share price is fetching $31.24 at the time of writing.

Web Travel Group Ltd (ASX: WEB)

Analysts at Macquarie have retained their outperform rating on this travel technology company's shares with a trimmed price target of $6.85. According to the note, the broker was pleased with the WebBeds owner's performance during the first half. It highlights that Web Travel delivered earnings that were in line with expectations. As a result of this strong performance, the broker is feeling increasingly confident that the company can achieve its FY 2027 growth targets. The Web Travel share price is trading at $4.60 on Wednesday.

The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

However, it hit a bit of a speed bump yesterday, falling 8%. 

Last month, The Motley Fool's Leigh Grant covered in depth how its unique and innovative product – PhotonAssay – is changing the way mining companies test ore. 

This kind of disruptive technology has seen its market capitalisation rapidly approach $1 billion and is quickly gaining investor attention. 

This could be an opportunity for investors to gain exposure to an innovative company at a slight discount.

What is Chrysos?

Chrysos combines science and software to create technology solutions for the global mining industry. 

Its flagship product is PhotonAssay. 

It can be used to detect a wide range of elements. However, it has proven particularly effective for assaying gold and is currently being rolled out across the gold mining industry.

PhotonAssay delivers faster, safer, more accurate, and environmentally friendly analysis of gold, silver, and complementary elements. 

The technology has rapidly displaced slower, more hazardous, and costly processes. It has quickly become an innovative and valuable mining industry solution.

AGM at a glance

Yesterday, the company held its 2025 AGM, and reiterated FY26 guidance of:

• FY26 Total Revenue range of $80m to $90m
• FY26 EBITDA range of $20m to $27m

Following the AGM, the team at Bell Potter upgraded this ASX industrials stock to a buy rating. This was along with an increased price target. 

It seems the broker believes Monday's 8% decline in share price could be an opportunity for investors to get in at a discount. 

Here's what the broker had to say. 

Industry adoption accelerating

In a report yesterday from Bell Potter, it highlighted the year-to-date (YTD) financial update (to 31 October 2025). 

According to the report, revenue for this ASX industrials stock was $28.9m, up 54% year over year (YoY). 

The broker also noted the company now has 41 deployed units, with recent deployments in Ontario and Norseman, two units currently being installed in Perth, two new lease agreements with ALS and Acrux Gold, and an MoU with Allied Gold for two additional units. 

Upcoming installations include C79's first Newmont unit in Ghana, as well as additional units for Bureau Veritas in Chile, MSALABS in Canada, and Allied Gold in West Africa.

The company's industry adoption has accelerated over the past year, driven by its new Master Services Agreement with Newmont and expanding relationships with major commercial labs. 

The exploration upcycle is expected to provide additional growth, supporting an EBITDA beat, and further accelerating adoption of PhotonAssay technology.

Buy recommendation for this ASX industrials stock

After previously having a hold rating on Chrysos shares, Bell Potter has upgraded the shares to a buy recommendation with an upgraded price target of $9.40. 

This ASX industrials stock closed yesterday at $8.04 each. 

With Bell Potter's updated price target, the broker indicates an upside of 16.92%. 

Our C79 valuation is driven by a discounted cash flow model of the company's expected PhotonAssayTM deployment and resulting sales, under a leasing model. We also recognise a corporate cost valuation allowance.

The post Should you buy the dip on this soaring ASX industrials stock? appeared first on The Motley Fool Australia.

The surging stock in question is precious metals testing company Chrysos Corporation Ltd (ASX: C79).

On 9 April you could have picked up Chrysos shares at a one-year closing low of $3.49 each. (The All Ords hit its 52-week low on 7 April.)

On Monday, Chrysos shares closed changing hands for $8.77 apiece, putting them up 151.3% in only seven months. Or enough to turn a $10,000 investment into $25,129.

Boom!

But if you think the ship has already sailed on this surging ASX All Ords stock, you may want to have another think.

That's according to Jason Pohl, a partner at ECP Asset Management. The ECP Growth Companies fund owns Chrysos shares, and Pohl said he likes the company's outlook (courtesy of The Australian Financial Review).

Here's why.

ASX All Ords stock on the growth path

"Chrysos makes gold testing faster, cleaner and simpler," said Pohl.

And he's bullish on the ongoing potential of the ASX All Ords stock's metal testing machines.

According to Pohl:

Its PhotonAssay machines deliver highly accurate results in minutes rather than days and avoid cyanide and lead, removing a major safety and compliance burden for labs and miners. That speed matters where faster turnaround improves mine drill plans and operational grade control.

Citing the company's core strength, Pohl concluded:

With a distinctive value proposition, a lease-driven model that scales with use, and an exceptional chief executive, Dirk Treasure, the Chrysos team has the ingredients for steady, scalable compounding.

What's been happening with Chrysos shares?

Chrysos released its full year FY 2025 results on 26 August.

Highlights included revenue of $66.1 million, up 46% from FY 2024.

Earnings before interest, taxes, depreciation and amortisation (EBITDA) of $16.1 million were up 80% from the prior year, with the company noting that economies of scale drove profitability.

Over the 12 months, the ASX All Ords stock deployed 11 PhotonAssay units, which brought the total to 40 units deployed.

And the company signed nine new leases in FY 2025, bringing total contracted PhotonAssay units to 59. That includes a Master Services Agreement and initial lease with the world's biggest gold miner, Newmont Corp (ASX: NEM).

Looking ahead, the ASX All Ords stock provided FY 2026 guidance for revenue in the range of $80 million to $90 million and EBITDA between $20 million and $27 million.

The post Up 151% since April, how this surging ASX All Ords stock can keep charging higher appeared first on The Motley Fool Australia.

With its market capitalisation now approaching the $1 billion mark, investors are asking: Could this mining technology innovator be the next ASX unicorn?

Reinventing how miners test ore

Chrysos is transforming one of the most fundamental processes in mining: how miners test ore. Its PhotonAssay technology replaces the traditional fire-assay method, which involves melting samples at high temperatures using lead and other hazardous materials.

Instead, PhotonAssay uses high-energy X-rays to measure gold and other metals in a sample within minutes. The result? Faster, safer, and more accurate analysis, which is a potential game-changer for the global mining industry.

Adoption of the technology has accelerated rapidly. Major miners and laboratories worldwide have signed long-term leases for PhotonAssay units. Even more telling, industry veteran Bill Beament, who famously built Northern Star Resources Ltd (ASX: NST) into one of Australia's largest gold producers, owns over 1 million shares in Chrysos. That's the kind of endorsement that tends to get investors' attention.

Strong growth and global expansion

In FY25, Chrysos continued to scale up its operations and financial performance.

• Deployments & contracts: The company installed 11 new PhotonAssay units, taking its total to 40, and signed nine new leases (plus four more after year-end), bringing total contracted units to 62.
  
• New customers: Major deployments included Newmont's sites in Ghana and Suriname and OceanaGold in New Zealand.
  
• Financials: Revenue rose 46% to $66.1 million, while operating earnings (EBITDA) jumped 80% to $16.1 million, lifting margins to 24%.
  
• Cash flow: Positive operating cash flow of $8.8 million supported ongoing investment and expansion.
  

For FY26, management expects revenue to be between $80 million and $90 million and EBITDA to be between $20 million and $27 million, suggesting another year of solid growth.

Closing in on unicorn status

With a share price rallying strongly and expanding contracts with some of the world's biggest gold producers, Chrysos is edging closer to a $1 billion valuation. That would put it in rarefied air among ASX tech-industrial companies — particularly for one serving the resources sector.

Chrysos may not have the name recognition of Australia's tech darlings, but its combination of cutting-edge science, growing global adoption, and recurring-revenue model has the hallmarks of a business on the rise.

Whether it ultimately reaches unicorn status will depend on continued execution and broader industry adoption, but for now, this mining-tech innovator is one to watch as it brings 21st-century technology to one of the world's oldest industries.

The post Is this mining tech company about to become the ASX's next unicorn? appeared first on The Motley Fool Australia.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

Chrysos Corporation Ltd (ASX: C79)

The Chrysos Corporation share price is up 19% to $4.91. This follows news that the mining technology company has signed an agreement with gold giant Newmont Corporation (ASX: NEM). The agreement will see Newmont use Chrysos' PhotonAssay technology for its gold mining projects. The two parties have also entered into a contract for an initial PhotonAssay unit to be installed at its Ahafo mine in Ghana, with deployment expected in the first half of FY 2026. Chrysos CEO Dirk Treasure commented: "We are proud to have secured both a Master Services Agreement and an initial lease contract with the industry's leading gold miner."

GQG Partners Inc (ASX: GQG)

The GQG Partners share price is up 5.5% to $2.28. Investors have been buying this investment company's shares following the release of latest funds under management (FUM) update. GQG Partners reported FUM of US$163.6 billion. This is up from US$161.9 billion at the end of March. The company also announced its quarterly dividend, which will be 5.87 cents per share. This annualises to a dividend yield just over 10%.

Macquarie Group Ltd (ASX: MQG)

The Macquarie Group share price is up almost 5% to $205.28. This has been driven by the release of the investment bank's full year results this morning. Macquarie reported a net profit of $3.72 billion for the 12 months. This was up 5% year on year and slightly ahead of consensus estimates. Commenting on the result, CEO Shemara Wikramanayake said: "Against a backdrop of ongoing market and economic uncertainty, Macquarie's client franchises remained resilient over the past year, delivering new business origination and underlying income growth, contributing to our history of unbroken profitability."

Webjet Group Ltd (ASX: WJL)

The Webjet Group share price is up 4% to 83.5 cents. This morning, this online travel agent revealed that an undisclosed buyer was looking to acquire an additional 5% stake. It said: "WJL became aware after market close of an undisclosed buyer seeking to acquire up to 5.0% of the shares in WJL (excluding current interest) representing approximately 19.6 million shares in WJL at a fixed cash price of $0.80 per share, with the ability to increase the offer size at the buyer's discretion. The undisclosed buyer is said to have an undisclosed interest below 5%."

The post Why Chrysos, GQG Partners, Macquarie, and Webjet shares are storming higher today appeared first on The Motley Fool Australia.

Four ASX shares that are rising more than most today are listed below. Here's why they are jumping:

Bubs Australia Ltd (ASX: BUB)

The Bubs Australia share price is up 22% to 12 cents. Investors have been buying this infant formula company's shares following the release of a second quarter and first half update. Bubs reported group gross revenue of $32.9 million for the quarter, which is a 42% increase on the prior corresponding period. This led to the company posting positive EBITDA of $2.9 million for the first half. This is a solid turnaround from the $6.8 million EBITDA loss it recorded in the prior corresponding period. In light of this, management has reaffirmed its guidance for FY 2025. It continues to expect revenue of $102 million, a gross margin greater than 40%, and EBITDA breakeven.

Chrysos Corporation Ltd (ASX: C79)

The Chrysos Corporation share price is up 4% to $5.17. This follows the release of the mining technology company's second quarter update. Chrysos reported unaudited revenue of $15.3 million. This was up 12% quarter on quarter and 53% year on year to $15.3 million. Management advised that this was driven primarily by international revenue and sample volume growth. CEO Dirk Treasure said: "Our significant sales success continued into the second Quarter of FY25 with two new contracts signed, building on four new contracts in the first Quarter. This momentum reflects the ongoing market penetration of our PhotonAssay technology and the efficacy of our customer diversification strategy."

JB Hi-Fi Ltd (ASX: JBH)

The JB Hi-Fi share price is up 3.5% to $101.58. This appears to have been driven by a broker note out of Citi. According to the note, the broker has reaffirmed its buy rating on the retail giant's shares with an improved price target of $110.00 (from $85.00). Citi is feeling positive about household spending in FY 2025 and feels there is upside risk to consensus estimates for JB Hi-Fi.

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is up 9% to $9.09. This follows the release of the uranium miner's quarterly update. Paladin Energy produced 638,409 pounds of uranium during the quarter, which was in line with management expectations. The company also revealed that it remains on track to meet its revised production guidance of 3.0 million to 3.6 million pounds of U3O8 in FY 2025. CEO Ian Purdy said: "We continue to de-risk the operation but recognise the LHM is still ramping up to full production and patience is required as our local team steadily achieves their goals."

The post Why Bubs, Chrysos, JB Hi-Fi, and Paladin Energy shares are storming higher today appeared first on The Motley Fool Australia.

In early trade, the ASX All Ords stock was up 9% to $5.40.

The mining technology company's shares have pulled back a touch since then but remain up almost 5% to $5.19 at the time of writing.

Why is this ASX All Ords stock jumping?

Investors have been fighting to get hold of the company's shares after it revealed "significant sales success" during the second quarter of FY 2025.

According to the release, unaudited revenue was up 12% quarter on quarter and 53% year on year to $15.3 million. This was driven primarily by international revenue and sample volume growth.

Chrysos' flagship product is PhotonAssay. It delivers faster, safer, more accurate and environmentally friendly analysis of gold, silver, copper, and other elements.

Management revealed that sample volumes totalled 1.6 million, reflecting 18% growth quarter on quarter and 53% growth year on year.

Also supporting its growth were two contracts signed with OceanaGold Corporation and SGS. They built on four contracts in the first quarter of FY 2025, bringing the total number of contracted units to 56. Though, only 34 units are currently deployed.

There was no earnings update with the release, but management did provide investors with its cash flow statement. It revealed that it recorded cash receipts of $11.7 million from PhotonAssay customers. This led to net operating cash inflows for the quarter totalling $1.5 million.

At the end of the period the ASX All Ords stock had a cash position of $26.6 million and $95 million in undrawn debt available. Management believes this means it is well-funded to support continued PhotonAssay unit growth.

Guidance reaffirmed

The ASX All Ords stock's managing director and CEO, Dirk Treasure, was pleased with the quarter. He commented:

Our significant sales success continued into the second Quarter of FY25 with two new contracts signed, building on four new contracts in the first Quarter. This momentum reflects the ongoing market penetration of our PhotonAssay technology and the efficacy of our customer diversification strategy. Similarly, sample volumes grew a healthy 18% Quarter-on-Quarter, signaling strong market uptake across our mining and laboratory customers in key mining hubs.

In light of its strong first half, Treasure has reaffirmed the company's FY 2025 revenue and earnings guidance. He adds:

Increased sample volumes, together with our growing international unit footprint have driven 12% Quarter-on-Quarter revenue growth. We remain on track to achieve our FY25 guidance of $60-$70m in revenue and $9-$19m in EBITDA. With PhotonAssay units deployed across multiple geographies, we continue to monitor market indicators for signs of a broader improvement in the gold industry cycle and are ready to capture this upside through latent unit capacity.

The post ASX All Ords stock jumps 9% on 'significant sales success' appeared first on The Motley Fool Australia.

Four ASX shares that are rising more than most today are listed below. Here's why they are charging higher:

Adairs Ltd (ASX: ADH)

The Adairs share price is up over 13% to $2.63. This has been driven by the release of the furniture and homewares retailer's first quarter update. Adairs reported a 4.8% year on year increase in unaudited sales for the first 16 weeks of FY 2025. This was driven almost entirely by the core Adairs brand, which reported sales growth of 8.6%. Mocka sales were up 0.4% and Focus on Furniture sales were down 3.7% over the same period last year. Management also revealed that its gross margin is up ~50 basis points on last year.

Chrysos Corporation Ltd (ASX: C79)

The Chrysos Corporation share price is up 7% to $5.03. This follows the release of the mining technology company's quarterly update. Chrysos reported unaudited revenue of $13.7 million for the first quarter. This represents 2% growth quarter on quarter and 54% year on year. Chrysos' CEO, Dirk Treasure, commented: "The first Quarter of 2025 not only saw Chrysos sign four new unit leases and deliver year-on-year sample and revenue growth of 30% and 54% respectively, it also marked the installation of our first USA-based PhotonAssay unit. This unit is the first of several deployments scheduled at the Barrick-Newmont NGM operation, representing Barrick's continuing adoption of our technology across its global network."

Karoon Energy Ltd (ASX: KAR)

The Karoon Energy share price is up 1.5% to $1.41. This morning, this energy producer released its third quarter update and revealed a 25% increase in quarterly production compared to the second quarter. This reflects a 44% increase in Bauna production, which helped offset a 10% decline in Who Dat production. The latter was impacted by seasonal hurricane-related shut-ins and planned maintenance. Also going down well with shareholders is news that the company's board has announced another US$25 million share buyback.

Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix Pharmaceuticals share price is up almost 4% to $21.90. This follows news that the United States Food and Drug Administration (FDA) has accepted Telix's New Drug Application (NDA) for Pixclara. It is an agent for the imaging of glioma. Telix executive, Kevin Richardson, said: "Telix believes that the FDA approval of Pixclara will drive a step-change for brain cancer imaging in the U.S., and bring it into line with a more advanced standard of care currently used in other markets."

The post Why Adairs, Chrysos, Karoon Energy, and Telix shares are charging higher appeared first on The Motley Fool Australia.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

Chrysos Corporation Ltd (ASX: C79)

The Chrysos share price is up 4% to $5.68. This follows the release of the mining technology company's full year results this morning. Chrysos reported a 69% increase in revenue to $45.4 million and a 156% jump in EBITDA to $9 million. Management advised that this was driven by strong demand for its flagship PhotonAssay product. It provides mining companies with faster, safer, more accurate and environmentally friendly analysis of gold, silver, copper and other elements. The company has provided guidance for FY 2025. It expects total revenue of $60 million to $70 million and EBITDA of $9 million to $19 million.

Nanosonics Ltd (ASX: NAN)

The Nanosonics share price is up 16% to $3.14. This has been driven by the release of the medical device company's full year results. Nanosonics reported a 2% increase in sales revenue and recurring revenue growth of 9% to $121.8 million. And while the company's profits tumbled by 35% to $13 million, investors have been willing to look beyond this. Particularly given that the profit decline was driven by investments in its long-term growth strategy.

Strike Energy Ltd (ASX: STX)

The Strike Energy share price has jumped 19% to 19.7 cents. This morning, this energy producer released an update on activities at the Erregulla Deep-1 exploration well. The company revealed that it has observed positive indications on mud logs and logging while drilling tools of porous gas charged sands. Investors appear hopeful that a change of fortune is coming after some disappointing exploration results in recent months.

Worley Ltd (ASX: WOR)

The Worley share price is up 3.5% to $14.58. Investors have been buying the professional services company's shares after it released its full year results and reported an 18% increase in revenue to $11.6 billion and a 24% jump in underlying EBITDA to $751 million. Worley's CEO, Chris Ashton, commented: "We're consistently delivering on our strategy as demonstrated by increased earnings, margins and cash flow. Our aggregated revenue represents the highest in Worley's history, with increases across all regions and each of the three segments of energy, chemicals and resources contributing to this result."

The post Why Chrysos, Nanosonics, Strike Energy, and Worley shares are racing higher today appeared first on The Motley Fool Australia.

Two such examples are listed below, with these ASX All Ords stocks heading in very different directions today. Let's see what they reported:

Chrysos Corporation Ltd (ASX: C79)

The Chrysos share price is up over 4% to $5.70 this morning after investors cheered on the mining technology company's FY 2024 results.

For the 12 months ended 30 June, the ASX All Ords stock reported a 69% increase in revenue to $45.4 million and a whopping 156% jump in EBITDA to $9 million.

This was driven by strong demand for its flagship PhotonAssay product, which delivers faster, safer, more accurate and environmentally friendly analysis of gold, silver, copper and other elements.

Chrysos' managing director and CEO, Dirk Treasure, commented:

The business continues to see increasing PhotonAssay use with customer sample volumes building strongly in global markets. Along with ongoing endorsement from major miners and laboratories in public forums and market announcements, we are also observing heightened interest in the technology through our commercial presence across four continents.

The ASX All Ords stock expects its growth to continue in FY 2025. It has provided guidance for total revenue of $60 million to $70 million and EBITDA of $9 million to $19 million.

Electro Optic Systems Holdings Ltd (ASX: EOS)

The EOS share price isn't having a good day and is down almost 13% to $1.56. This follows the release of the defence and space technology company's half year results.

The ASX All Ords stock reported an impressive 92% increase in revenue to $142.6 million. This increase was predominantly driven by the Defence segment which generated revenue of $101.4 million in the half-year. This is double the $50.7 million recorded in the prior corresponding period.

However, despite this sizeable lift in its top line, it wasn't enough to take EOS into profit. The company reported a loss after tax of $3.5 million for the half. Though, it should be noted that this was a significant improvement on its loss of $32.4 million in the prior corresponding period.

In addition, EOS revealed a net cash outflow from operating activities of $30.6 million. This is down $61.3 million from an inflow of $30.7 million a year earlier. Management blamed this partly on additional payments for long lead times items.

Nevertheless, the ASX All Ords stock ended the period with a cash balance of $52.2 million.

The post 2 ASX All Ords stocks making big moves on results day appeared first on The Motley Fool Australia.

Four ASX shares that have failed to follow the market's lead today are listed below. Here's why they are falling:

Bellevue Gold Ltd (ASX: BGL)

The Bellevue Gold share price is down 22% to $1.43. Investors have been selling this gold miner's shares after it raised funds via an institutional placement. The company revealed that it has received firm commitments for a $150 million fully underwritten institutional placement at $1.55 per new share. This represents a 15.3% discount to where its shares last traded. Proceeds will be used to repay debt, unlocking project free cash flow to allow it to self-fund its expansion in line with its updated five-year growth plan, and to support accelerated exploration and growth. That growth plan also revealed significantly higher than expected costs in FY 2025, which could also be weighing on its shares today.

Chrysos Corporation Ltd (ASX: C79)

The Chrysos share price is down a further 1.5% to $4.91. This mining solutions company's shares have been under pressure since the release of its quarterly update on Thursday. Chrysos reported a 58% increase in fourth quarter revenue to $13.5 million. This meant that FY 2024 revenue was up 69% to $45.4 million. While this was clearly strong growth, this positive was offset by disappointing guidance for FY 2025. In response, Bell Potter downgraded its shares to a hold rating with a reduced price target of $5.70 (from $7.60). It said: "The revenue and EBITDA guidance underwhelmed, coming in materially below expectations at $60-70m (BPe old $78.5m) and $9-19m (BPe old $24.1m), respectively."

Meteoric Resources NL (ASX: MEI)

The Meteoric Resources share price is down 10.5% to 10.75 cents. This decline has also been driven by an institutional placement. The rare earths developer has received firm commitments to raise $27.5 million at an 8.3% discount of $0.11 per new share. Management notes that the placement proceeds "will be applied towards the 100%-owned Caldeira Project, which has the potential to become one of the world's lowest cost sources of rare earths outside of China."

Newmont Corporation (ASX: NEM)

The Newmont share price is down 2.5% to $70.59. This follows a sharp pullback in the gold price overnight after traders took profit following strong gains recently. It isn't just this gold giant that is falling today, the sector is a sea of red. So much so, at the time of writing, the S&P/ASX All Ordinaries Gold index is down 2.5%.

The post Why Bellevue Gold, Chrysos, Meteoric Resources, and Newmont shares are falling today appeared first on The Motley Fool Australia.

Shares in Chrysos Corporation Ltd (ASX: C79), a precious metal assaying equipment manufacturer, are down 7.8% to $5.06 today. At the time of writing, the disappointing move ranks the company as the third-worst-performing stock inside the S&P/ASX All Ordinaries Index (ASX: XAO).

Some investors are deciding to dip on Chrysos today despite its fourth-quarter achievements.

Quarterly growth brushed aside

Here are the speedy key stats from Chrysos' fourth quarter (all figures are unaudited):

• Total revenue of $13.5 million, up 58% year-on-year
• FY24 revenue up 69% to $45.4 million
• Samples processed up 27% year-on-year to 1.2 million
• Two additional units deployed in Q4, reaching 29 deployed units
• Cash balance of $61.1 million as of 30 June 2024

Continuing to expand its installations of the PhotonAssay unit, Chrysos delivered two deployments during the fourth quarter — one in Africa and the other in Canada. At the same time, the company achieved another consecutive quarter of record sample testing volumes.

As shown in the image above, revenue across the Asia-Pacific region (APAC) was relatively flat compared to the prior corresponding period, which might be weighing down the ASX All Ords stock today.

However, the Americas and the Europe, Middle East, and Africa (EMEA) regions grew substantially year over year, further diversifying the company's revenue beyond Australia.

Working our way down from revenue, Chrysos indicated its gross margins are holding between 70% and 80%.

What's ahead for this ASX All Ords stock?

Chrysos has supplied some visibility for FY2025.

The company anticipates revenue between $60 million and $70 million in FY25. At the midpoint, this would imply an increase of 43% from today's unaudited FY24 revenue, a considerable reduction from the 69% growth prior.

Investors might be wary of slowing revenue growth when this ASX All Ords stock trades on a price-to-sales (P/S) ratio of around 13 times. Still, Chrysos CEO Dirk Treasure insists, "Chrysos' sales opportunity pipeline remains strong […]".

Furthermore, earnings before interest, taxes, depreciation, and amortisation (EBITDA) are expected to land between $9 million and $19 million in FY25.

The Chrysos share price is down 39% since the beginning of the year.

The post ASX All Ords stock sinking 8% despite rocketing revenue appeared first on The Motley Fool Australia.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising today:

Chrysos Corporation Ltd (ASX: C79)

The Chrysos Corporation share price is up almost 6% to $5.53. This is despite there being no news out of the mining technology company today. However, it is worth noting that the company did reveal some insider buying earlier this week. As I covered here, its director Gregory Holt picked up 12,000 shares through an on market trade on 12 June. Holt paid an average of $5.05 per share, which equates to a total consideration of $60,600. Chrysos Corporation shares are down by almost 35% since the start of the year and to a level that this director appears to believe is attractive.

Hansen Technologies Limited (ASX: HSN)

The Hansen Technologies share price is up over 2% to $4.15. This may have been driven by a broker note out of Goldman Sachs this morning. Although the broker has only put a neutral rating on the billing technology company's shares, its price target of $4.85 is materially higher than current levels. In fact, even after today's gain, Hansen Technologies shares have potential upside of 17% according to Goldman. The broker notes that Hansen Technologies' "undemanding valuation reflects Powercloud and management uncertainty."

Pantoro Ltd (ASX: PNR)

The Pantoro share price is up 2.5% to 8.5 cents. This morning, this gold miner revealed that its board has approved the initial 85,000 metre growth program for FY 2025. The company's managing director, Paul Cmrlec, said: "This is a very exciting period in the development of the Norseman goldfield. For the first time we are in a position to re-develop the Norseman Mainfield with an outstanding balance sheet position, and operations generating strong cashflow."

WA1 Resources Ltd (ASX: WA1)

The WA1 Resources share price is up 21% to $19.67. Investors have been buying the niobium explorer following the release of results from the initial metallurgical testwork program. This program is being undertaken on niobium mineralisation from its Luni deposit at the 100% owned West Arunta Project in Western Australia. The good news is that the program has produced high-grade niobium concentrates with low impurities and at industry-comparable recovery rates through a practical two stage flotation regime.

The post Why Chrysos, Hansen Technologies, Pantoro, and WA1 Resources shares are pushing higher appeared first on The Motley Fool Australia.

This is because insider buying is often regarded as a bullish indicator, as few people know a company and its intrinsic value better than its directors.

If they are buying, it could be a sign that they are confident in the direction the company is heading and/or see value in its shares.

With that in mind, listed below are a few ASX shares that have reported meaningful insider buying recently.

And as they are all down heavily year to date, it's possible that these directors believe they have been oversold. Let's see what has been happening:

Chrysos Corporation Ltd (ASX: C79)

This mining technology company's shares are down a disappointing 40% since the start of the year.

One director that is taking advantage of this weakness to buy their first shares in the PhotonAssay creator is Gregory Holt. According to change of director's interest notice, Holt picked up 12,000 shares through an on-market trade on 12 June.

The insider paid an average of $5.05 per share, which equates to a total consideration of $60,600.

Shaw & Partners would likely be very supportive of this purchase. Last month, the broker put a buy rating and $7.50 price target on the company's shares.

IDP Education Ltd (ASX: IEL)

This heavily shorted language testing and student placement company's shares are down 23% in 2024 and 37% on a 12-month basis. This has been driven largely by disruption in key markets caused by changes to student visa rules, which is weighing heavily on its performance.

Nevertheless, one of the company's non-executive directors appears to remain positive on the future and sees this as a buying opportunity.

A change of director's interests notice shows that Tracey Horton bought 1,300 shares through an on-market trade on 7 June. Horton paid a total of $19,691.65 for the shares, which equates to a price of approximately $15.15 per share.

Goldman Sachs currently has a buy rating and $21.75 price target on its shares. So, this insider could do very well if the broker is on the money with its recommendation.

Lendlease Group (ASX: LLC)

Finally, this property developer's shares have lost 27% of their value this year.

The company's independent non-executive director, Elizabeth M. Proust, AO, has taken advantage of this weakness to top up her position.

Ms Proust picked up 20,000 shares on 11 June through an on-market trade. The insider paid an average of $5.675 per share, which represents a total consideration of $113,500. This boosts her holding to a total of 123,061 Lendlease shares.

While none of the major brokers rate Lendlease as a buy, they do see value in its shares. For example, UBS has a neutral rating and $7.10 price target. This is 30% higher than where its shares trade today.

The post Insiders are buying these ASX shares after selloffs appeared first on The Motley Fool Australia.

Here's why these four shares are underperforming the market and dropping into the red this morning:

29Metals Ltd (ASX: 29M)

The first ASX mining share that has taken a tumble today is 29Metals. Its shares are down over 5% to 44.5 cents.

This morning, the copper miner released its quarterly update and posted an 11.5% increase in copper production but a 77.3% decline in zinc production. Also heading in the wrong direction were its C1 costs, which increased 32% quarter on quarter to US$4.05 per pound of copper sold.

This reflects production disruption at the Capricorn Copper operation following heavy rainfall. This operation is now being suspended.

Chrysos Corporation Ltd (ASX: C79)

Another ASX mining solutions share falling on Tuesday is Chrysos Corporation. It is an assay services provider to the global mining industry through its PhotonAssay technology.

Chrysos shares are down 2% to $6.72 at the time of writing.

This morning, it released its quarterly update and reported revenue of $12.9 million for the three months. This represents a 28% quarter on quarter increase and a 96% year on year.

The main disappointment appears to have come from management's guidance for FY 2024. It expects to report revenue of $45 million and EBITDA of $8.5 million. The former is short of its original guidance range of $48 million to $58 million and the latter is at the bottom end of its guidance range of $7 million to $17 million.

De Grey Mining Limited (ASX: DEG)

The De Grey Mining share price is down 5% to $1.26 this morning.

This ASX gold mining share appears to have been dragged lower largely by a sharp decline in the gold price overnight.

In other news, the gold developer released its quarterly activities report after the market close on Monday. It ended the period with cash of $319 million and no debt.

De Grey also confirmed that it continues to target first gold production in the second half of 2026, subject to receipt of regulatory approvals.

In other news, there is speculation that Gold Road Resources Ltd (ASX: GOR) could sell its stake in De Grey Mining to fund a major acquisition.

Winsome Resources Ltd (ASX: WR1)

A third ASX mining share under pressure on Tuesday is Winsome Resources. Its shares are currently down 2.5% to $1.26.

And while the lithium explorer released its quarterly update today, this decline appears to be largely down to broad weakness in the lithium industry.

After all, as Winsome is still in the exploration stage, its update didn't contain anything unexpected.

The post 4 ASX mining shares being hammered on quarterly updates appeared first on The Motley Fool Australia.

In case you're not familiar with Chrysos, it provides technology solutions to the global mining industry.

Its flagship product is PhotonAssay, which was developed at Australia's national science agency, CSIRO.

PhotonAssay delivers faster, safer, more accurate, and environmentally-friendly analysis of gold, silver, copper and other elements. The company notes that the technology has rapidly displaced slower, more hazardous and costly processes to become the mining industry's most innovative and valuable assaying solution.

Last month, the company revealed that its growing popularity with end users helped underpin a sizeable 62% increase in revenue to $19.8 million during the first half of FY 2024.

Why is Chrysos an ASX tech share to buy?

Bell Potter notes that UK-based mining services provider Capital has just released its results and outlook for 2024.

Its subsidiary MSALABS has the largest international network of Chrysos PhotonAssay technology.

According to the note, deployments into MSALABS's network is on track and the company has reiterated its multi-year expansion strategy, which emphasises PhotonAssay deployments.

Bell Potter highlights that Capital advised that "MSALABS relationship with Chrysos remains strong and will see the deployment of 21 units" in 2024. This compares to its previous guidance for these 21 deployments to be made by 2025.

It sees this as a big positive and appears to believe it supports its view that PhotonAssay is on its way to winning a significant market share. It commented:

We believe C79's disruptive PhotonAssay technology will command a significant foothold within the large gold assaying market (BPe 25% market penetration by FY30), with current lease agreements providing good near-term deployment visibility. These lease agreements with some of the largest gold miners and international laboratory businesses provide third-party technical and commercial validation for PhotonAssay technology adoption, which should support further industry take-up.

Big returns could be coming

The note reveals that Bell Potter has reaffirmed its buy rating on the ASX tech share with a price target of $8.30.

Based on its current share price of $6.55, this implies potential upside of approximately 27% for investors over the next 12 months.

The post Why Bell Potter thinks this ASX tech share is a top buy appeared first on The Motley Fool Australia.

Remember, each dollar you save on the buying cost is a dollar added to your eventual returns.

So while it's impossible to time the market, entry cost matters.

Here are three ASX shares going for cheap that I can think of:

Just the start of a long journey

Xero Ltd (ASX: XRO) is a long-time favourite for growth investors, but its share price has recently stalled somewhat.

In fact, the accounting software maker is now more than 10% down since the start of September.

But the long-term outlook remains positive under chief executive Sukhinder Singh Cassidy, who has been at the helm for a year now.

She was brought in with a mission to transform the former growth-at-all-costs business to a growth-with-positive-cash-flow model.

There will be hiccups along the way, which is why the stock has spluttered over the past six months.

But long-term investors know the shift will take some time.

Professional investors certainly seem to appreciate this, with 12 out of 19 analysts currently surveyed on CMC Invest rating Xero as a buy.

The ASX shares for economic optimists

Mining technology provider RPMGlobal Holdings Ltd (ASX: RUL) is also another stock that's made plenty of people rich in the past.

The share price has more than doubled over the five years, although it's now 17% off its December 2021 peak.

And that could make for an ideal buying opportunity.

The macroeconomic tailwinds are certainly in place.

In the west, interest rates are already stabilising and a cut could even be not too far away. 

Meanwhile, in China, its fight against deflation continues. This could mean direct or indirect economic stimulus could be imminent.

In both regions, the developments could drive up consumption, send commodity prices higher, and RPMGlobal's clients could have more to spend on tech.

Both Moelis and Veritas recommend RPMGlobal shares as a strong buy, according to CMC Invest.

A cheapie that's 73% more expensive than a year ago

Staying with the mining theme, Chrysos Corporation Ltd (ASX: C79) provides assay services with unique technology that speeds up the testing with higher accuracy compared to traditional methods.

You may raise your eyebrows that I call this a bargain, since the stock price has rocketed 73% higher over the past 12 months.

However, Chrysos shares are down almost 21% since 10 January, presenting a dip.

For the same reasons as RPMGlobal, I'm bullish on Chrysos.

The high part of the mining cycle could come in the next few years, and service providers like Chrysos could really cash in.

All three experts surveyed on the CMC Invest broking platform rate the shares as a buy.

The post 3 ASX shares I think you'll be glad you bought at these prices appeared first on The Motley Fool Australia.

There are plenty of moments when faith will be tested, but as long as the original investment thesis still holds and any problems are deemed to be temporary, long-termers need to fight through their anxiety.

Here's a pair of such cheap shares representing quality companies that could be a bargain right now:

Japan 'disappointing', but home market still going strong

As the dominant pizza retailer in the country, Domino's Pizza Enterprises Ltd (ASX: DMP) used to be a market darling.

But a series of missteps in recent times has seen the stock price plummet more than 74% since September 2021.

Unfortunately, 2024 is off to a shocker as well.

After a January briefing to the market, Domino's share price plunged 31% in a single day.

Bell Potter advisor Christpher Watt agreed the earnings update was "disappointing".

"The business in Japan is underperforming and weighing on group performance," Watt told The Bull.

"However, results in Australia and New Zealand were positive."

That's why the Bell Potter team thinks it could be an ideal entry point for the fast food stock.

"We believe the stock has been oversold as Domino's remains a leader in the sector."

These cheap shares won't stay down for long

While Chrysos Corporation Ltd (ASX: C79) was one of the darlings of 2023, the new year has been less kind.

The share price has dived 18% since 10 January.

"Chysos was recently sold down after missing revenue expectations in the second quarter of fiscal year 2024," said Shaw and Partners senior investment advisor Jed Richards.

Chrysos' main product is named PhotonAssay, which tests samples for minerals like gold, copper, and silver on behalf of mining clients.

Richards is not worried about the downturn this year.

"Delays in the number of PhotonAssay unit installations reflect timing issues as opposed to a reduction in demand. 

"We view the share price reaction as overdone, presenting attractive entry levels for investors."

The post 2 'oversold' ASX shares to get onto right now at 'attractive entry levels' appeared first on The Motley Fool Australia.